UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Letermovir vs Valganciclovir for Prophylaxis of Cytomegalovirus in High-Risk Kidney Transplant Recipients: A Randomized Clinical Trial

JAMA : the journal of the American Medical Association, 2023-07, Vol.330 (1), p.33

2023

Volltextzugriff (PDF)

Calcineurin Inhibitor Nephrotoxicity

Clinical journal of the American Society of Nephrology, 2009-02, Vol.4 (2), p.481-508

2009

Volltextzugriff (PDF)

Clinical determinants of calcineurin inhibitor disposition: a mechanistic review

Drug metabolism reviews, 2016-01, Vol.48 (1), p.88-112

2016

Volltextzugriff (PDF)

Management of polyomavirus-associated nephropathy in renal transplant recipients

Nature reviews. Nephrology, 2012-07, Vol.8 (7), p.390-402

Kuypers, Dirk R J

2012

Volltextzugriff (PDF)

The histology of kidney transplant failure: a long-term follow-up study

Transplantation, 2014-08, Vol.98 (4), p.427-435

2014

Volltextzugriff (PDF)

Multidrug resistance protein 2 genetic polymorphisms influence mycophenolic acid exposure in renal allograft recipients

Transplantation, 2006-10, Vol.82 (8), p.1074-1084

2006

Volltextzugriff (PDF)

Donor Age and Renal P-Glycoprotein Expression Associate with Chronic Histological Damage in Renal Allografts

Journal of the American Society of Nephrology, 2009-11, Vol.20 (11), p.2468-2480

2009

Volltextzugriff (PDF)

Impact of POR28 on the pharmacokinetics of tacrolimus and cyclosporine A in renal transplant patients

Therapeutic drug monitoring, 2014-02, Vol.36 (1), p.71-79

2014

Volltextzugriff (PDF)

Intrapatient Variability of Tacrolimus Exposure in Solid Organ Transplantation: A Novel Marker for Clinical Outcome

Clinical pharmacology and therapeutics, 2020-02, Vol.107 (2), p.347-358

Kuypers, Dirk R.J.

2020

Volltextzugriff (PDF)

New insights into the pharmacokinetics and pharmacodynamics of the calcineurin inhibitors and mycophenolic acid: possible consequences for therapeutic drug monitoring in solid organ transplantation

Therapeutic drug monitoring, 2009-08, Vol.31 (4), p.416-435

2009

Volltextzugriff (PDF)

The impact of uridine diphosphate–glucuronosyltransferase 1A9 (UGT1A9) gene promoter region single‐nucleotide polymorphisms T—275A and C—2152T on early mycophenolic acid dose‐interval exposure in de novo renal allograft recipients

Clinical pharmacology and therapeutics, 2005-10, Vol.78 (4), p.351-361

2005

Volltextzugriff (PDF)

Reduced C0 concentrations and increased dose requirements in renal allograft recipients converted to the novel once-daily tacrolimus formulation

Transplantation, 2010-09, Vol.90 (5), p.523-529

2010

Volltextzugriff (PDF)

Clinical Efficacy and Toxicity Profile of Tacrolimus and Mycophenolic Acid in Relation to Combined Long-term Pharmacokinetics in de Novo Renal Allograft Recipients

Clinical pharmacology and therapeutics, 2004-05, Vol.75 (5), p.434-447

2004

Volltextzugriff (PDF)

Immunotherapy in Elderly Transplant Recipients: A Guide to Clinically Significant Drug Interactions

Drugs & aging, 2009-01, Vol.26 (9), p.715-737

Kuypers, Dirk R. J.

2009

Volltextzugriff (PDF)

From Nonadherence to Adherence

Transplantation, 2020-07, Vol.104 (7), p.1330-1340

Kuypers, Dirk R J

2020

Volltextzugriff (PDF)

Progressive decline in tacrolimus clearance after renal transplantation is partially explained by decreasing CYP3A4 activity and increasing haematocrit

British journal of clinical pharmacology, 2015-09, Vol.80 (3), p.548-559

2015

Volltextzugriff (PDF)

Pharmacokinetic modeling of enterohepatic circulation of mycophenolic acid in renal transplant recipients

Kidney international, 2014-06, Vol.85 (6), p.1434-1443

2014

Volltextzugriff (PDF)

Relationship between In Vivo CYP3A4 Activity, CYP3A5 Genotype, and Systemic Tacrolimus Metabolite/Parent Drug Ratio in Renal Transplant Recipients and Healthy Volunteers

Drug metabolism and disposition, 2018-11, Vol.46 (11), p.1507-1513

2018

Volltextzugriff (PDF)

CYP3A5 genotype is not associated with a higher risk of acute rejection in tacrolimus-treated renal transplant recipients

Pharmacogenetics and genomics, 2008-04, Vol.18 (4), p.339-348

2008

Volltextzugriff (PDF)

Skin problems in chronic kidney disease

Nature clinical practice. Nephrology, 2009-03, Vol.5 (3), p.157-170

Kuypers, Dirk RJ

2009

Volltextzugriff (PDF)

Expression of CYP3A5 and P-glycoprotein in renal allografts with histological signs of calcineurin inhibitor nephrotoxicity

Transplantation, 2011-05, Vol.91 (10), p.1098-1102

2011

Volltextzugriff (PDF)

Effects of CYP3A5 and MDR1 single nucleotide polymorphisms on drug interactions between tacrolimus and fluconazole in renal allograft recipients

Pharmacogenetics and genomics, 2008-10, Vol.18 (10), p.861-868

2008

Volltextzugriff (PDF)

Occupational radiation dose: percutaneous interventional procedures on hemodialysis arteriovenous fistulas and grafts

Radiology, 2012-07, Vol.264 (1), p.278-284

2012

Volltextzugriff (PDF)

Tacrolimus-Induced Neutropenia in Renal Transplant Recipients

Clinical journal of the American Society of Nephrology, 2011-03, Vol.6 (3), p.690-694

2011

Volltextzugriff (PDF)

1 – 25 von 156

Suche als RSS-Feed

Aktive Filter

KollektionElsevier ScienceDirect Journals Complete

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(152)
Mit Volltextzugriff
(95)

Publikationsform

Artikel
(154)
Buchkapitel
(2)

Sprache

Englisch
(155)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(125)
Life Sciences & Biomedicine
(124)
Humans
(118)
Male
(75)
Female
(73)
Transplantation
(73)
Middle Aged
(67)
Kidney Transplantation
(64)
Biological And Medical Sciences
(55)
Medical Sciences
(54)
Adult
(47)
Surgery
(47)
Aged
(37)
Pharmacology & Pharmacy
(36)
Urology & Nephrology
(34)
Immunosuppressive Agents - Therapeutic Use
(31)
Pharmacology. Drug Treatments
(31)
Prospective Studies
(29)
Immunology
(28)
Tacrolimus
(27)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Letermovir vs Valganciclovir for Prophylaxis of Cytomegalovirus in High-Risk Kidney Transplant Recipients: A Randomized Clinical Trial

Calcineurin Inhibitor Nephrotoxicity

Clinical determinants of calcineurin inhibitor disposition: a mechanistic review

Management of polyomavirus-associated nephropathy in renal transplant recipients

The histology of kidney transplant failure: a long-term follow-up study

Multidrug resistance protein 2 genetic polymorphisms influence mycophenolic acid exposure in renal allograft recipients

Donor Age and Renal P-Glycoprotein Expression Associate with Chronic Histological Damage in Renal Allografts

Impact of POR28 on the pharmacokinetics of tacrolimus and cyclosporine A in renal transplant patients

Intrapatient Variability of Tacrolimus Exposure in Solid Organ Transplantation: A Novel Marker for Clinical Outcome

New insights into the pharmacokinetics and pharmacodynamics of the calcineurin inhibitors and mycophenolic acid: possible consequences for therapeutic drug monitoring in solid organ transplantation

The impact of uridine diphosphate–glucuronosyltransferase 1A9 (UGT1A9) gene promoter region single‐nucleotide polymorphisms T—275A and C—2152T on early mycophenolic acid dose‐interval exposure in de novo renal allograft recipients

Reduced C0 concentrations and increased dose requirements in renal allograft recipients converted to the novel once-daily tacrolimus formulation

A Machine Learning-Driven Virtual Biopsy System For Kidney Transplant Patients

Clinical Efficacy and Toxicity Profile of Tacrolimus and Mycophenolic Acid in Relation to Combined Long-term Pharmacokinetics in de Novo Renal Allograft Recipients

Immunotherapy in Elderly Transplant Recipients: A Guide to Clinically Significant Drug Interactions

From Nonadherence to Adherence

Progressive decline in tacrolimus clearance after renal transplantation is partially explained by decreasing CYP3A4 activity and increasing haematocrit

Pharmacokinetic modeling of enterohepatic circulation of mycophenolic acid in renal transplant recipients

Relationship between In Vivo CYP3A4 Activity, CYP3A5 Genotype, and Systemic Tacrolimus Metabolite/Parent Drug Ratio in Renal Transplant Recipients and Healthy Volunteers

CYP3A5 genotype is not associated with a higher risk of acute rejection in tacrolimus-treated renal transplant recipients

Skin problems in chronic kidney disease

Expression of CYP3A5 and P-glycoprotein in renal allografts with histological signs of calcineurin inhibitor nephrotoxicity

Effects of CYP3A5 and MDR1 single nucleotide polymorphisms on drug interactions between tacrolimus and fluconazole in renal allograft recipients

Occupational radiation dose: percutaneous interventional procedures on hemodialysis arteriovenous fistulas and grafts

Tacrolimus-Induced Neutropenia in Renal Transplant Recipients

Aktive Filter

Suchergebnisse filtern